17 On the other hand, another meta‐analysis showed a trend toward higher stroke or embolism with DOACs compared to VKAs. 18 Other studies showed no significant difference between major bleeding, systemic thromboembolic events, or failure of resolution of LV thrombus between patients taking VKA or DOCAs. 19 , 20 Further randomized controlled trials are needed to compare the use of VKA to DOACs in LV thrombus, although they seem to be a promising treatment. 3.
← all excerpts
Left ventricular thrombus in a patient with recurrent ischemic stroke events-The role of echocardiography.
1
—
—